Stenvang, J.; Budinská, E.; van Cutsem, E.; Bosman, F.; Popovici, V.; Brünner, N.
An Explorative Analysis of ABCG2/TOP-1 mRNA Expression as a Biomarker Test for FOLFIRI Treatment in Stage III Colon Cancer Patients: Results from Retrospective Analyses of the PETACC-3 Trial. Cancers 2020, 12, 977.
https://doi.org/10.3390/cancers12040977
AMA Style
Stenvang J, Budinská E, van Cutsem E, Bosman F, Popovici V, Brünner N.
An Explorative Analysis of ABCG2/TOP-1 mRNA Expression as a Biomarker Test for FOLFIRI Treatment in Stage III Colon Cancer Patients: Results from Retrospective Analyses of the PETACC-3 Trial. Cancers. 2020; 12(4):977.
https://doi.org/10.3390/cancers12040977
Chicago/Turabian Style
Stenvang, Jan, Eva Budinská, Eric van Cutsem, Fred Bosman, Vlad Popovici, and Nils Brünner.
2020. "An Explorative Analysis of ABCG2/TOP-1 mRNA Expression as a Biomarker Test for FOLFIRI Treatment in Stage III Colon Cancer Patients: Results from Retrospective Analyses of the PETACC-3 Trial" Cancers 12, no. 4: 977.
https://doi.org/10.3390/cancers12040977
APA Style
Stenvang, J., Budinská, E., van Cutsem, E., Bosman, F., Popovici, V., & Brünner, N.
(2020). An Explorative Analysis of ABCG2/TOP-1 mRNA Expression as a Biomarker Test for FOLFIRI Treatment in Stage III Colon Cancer Patients: Results from Retrospective Analyses of the PETACC-3 Trial. Cancers, 12(4), 977.
https://doi.org/10.3390/cancers12040977